Navalign, LLC Pfizer Inc Transaction History

Navalign, LLC

$301 Million
Q1 2024

A detailed history of Navalign, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Navalign, LLC holds 11,528 shares of PFE stock, worth $323,360. This represents 0.11% of its overall portfolio holdings.

Number of Shares

11,528

Previous 14,221 18.94%

Holding current value

$323,360

Previous $409,000 22.0%

% of portfolio

0.11%

Previous 0.14%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$25.89 - $29.73 $69,721 - $80,062	-2,693 Reduced 18.94%	11,528 $319,000
Q4 2023 Jan 18, 2024	SELL	$26.13 - $33.94 $295,974 - $384,438	-11,327 Reduced 44.34%	14,221 $409,000
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $45,856 - $53,601	-1,429 Reduced 5.3%	25,548 $847,000
Q2 2023 Jul 14, 2023	SELL	$36.12 - $41.79 $81,992 - $94,863	-2,270 Reduced 7.76%	26,977 $989,000
Q1 2023 Apr 19, 2023	SELL	$39.39 - $51.28 $13,510 - $17,589	-343 Reduced 1.16%	29,247 $1.19 Million

Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $22,378 - $29,212	-536 Reduced 1.78%	29,590 $1.52 Million
Q3 2022 Nov 02, 2022	SELL	$43.76 - $53.42 $1,925 - $2,350	-44 Reduced 0.15%	30,126 $1.32 Million
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $21,496 - $25,488	-462 Reduced 1.51%	30,170 $1.58 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $62,540 - $77,495	-1,367 Reduced 4.27%	30,632 $1.52 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $47,518 - $70,437	-1,150 Reduced 3.47%	31,999 $1.89 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $11,971 - $15,378	-305 Reduced 0.91%	33,149 $1.43 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $42,230 - $47,839	1,176 Added 3.64%	33,454 $1.31 Million
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $1.08 Million - $1.22 Million	32,278 New	32,278 $1.17 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Navalign, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Navalign, LLC with notifications on news.

Account